Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hepion Pharmaceuticals Inc (HEPA)

Hepion Pharmaceuticals Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 491
  • Shares Outstanding, K 11,435
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,190 K
  • EBIT $ -15 M
  • EBITDA $ -14 M
  • 60-Month Beta 1.52
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.21
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -72.15
  • Most Recent Earnings $-2.15 on 05/19/25
  • Next Earnings Date 08/12/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0602 +32.89%
on 12/09/25
0.0869 -7.94%
on 11/11/25
+0.0060 (+8.11%)
since 11/10/25
3-Month
0.0460 +73.91%
on 10/01/25
0.0954 -16.14%
on 10/02/25
+0.0018 (+2.30%)
since 09/10/25

Most Recent Stories

More News
Hepion Pharmaceuticals Successfully Completes Application to the OTCQB

HEPA : 0.0800 (+14.29%)
Hepion Pharmaceuticals Announces Dr. Kaouthar Lbiati as Interim Chief Executive Officer

HEPA : 0.0800 (+14.29%)
Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq

HEPA : 0.0800 (+14.29%)
Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC

HEPA : 0.0800 (+14.29%)
Hepion Pharmaceuticals Announces Reverse Stock Split

HEPA : 0.0800 (+14.29%)
Hepion Pharmaceuticals Announces $9.0 Million Public Offering

HEPA : 0.0800 (+14.29%)
Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

HEPA : 0.0800 (+14.29%)
Hepion Pharmaceuticals Urges Shareholders to Approve Merger with Pharma Two B to Enhance Investment Potential

Hepion Pharmaceuticals urges shareholders to support its merger with Pharma Two B to enhance investment potential and address financial challenges.Quiver AI SummaryHepion Pharmaceuticals is urging its...

HEPA : 0.0800 (+14.29%)
Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

HEPA : 0.0800 (+14.29%)
Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

HEPA : 0.0800 (+14.29%)

Business Summary

Hepion Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. It is focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis and chronic hepatitis virus infection. The Company's lead drug candidate CRV431, reduces liver fibrosis and hepatocellular...

See More

Key Turning Points

3rd Resistance Point 0.1000
2nd Resistance Point 0.0900
1st Resistance Point 0.0850
Last Price 0.0800
1st Support Level 0.0700
2nd Support Level 0.0600
3rd Support Level 0.0550

See More

52-Week High 0.0954
Last Price 0.0800
Fibonacci 61.8% 0.0718
Fibonacci 50% 0.0645
Fibonacci 38.2% 0.0572
52-Week Low 0.0336

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar